- Home
- ZJYL
ZJYL
JIN MEDICAL INTERNATIONAL LTD.
as 04-18-2025 1:46pm EST
| Founded: | 2006 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 272.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.02 | EPS Growth: | 18.46 |
| 52 Week Low/High: | $0.56 - $4.38 | Next Earning Date: | 05-03-2025 |
| Revenue: | $23,502,010 | Revenue Growth: | 18.57% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest JIN MEDICAL INTERNATIONAL LTD. News
ZJYL Breaking Stock News: Dive into ZJYL Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
The Returns On Capital At Jin Medical International (NASDAQ:ZJYL) Don't Inspire Confidence
Simply Wall St.
3 months ago
Jin Medical International Full Year 2024 Earnings: EPS: US$0.023 (vs US$0.02 in FY 2023)
Simply Wall St.
5 months ago
Jin Medical International Ltd. (NASDAQ:ZJYL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
GlobeNewswire
6 months ago
Construction of JinMed's New Facility Begins in Chuzhou, China
Simply Wall St.
6 months ago
Some Investors May Be Worried About Jin Medical International's (NASDAQ:ZJYL) Returns On Capital
Simply Wall St.
9 months ago
Exploring Three Undiscovered Gems With Promising Potential
Simply Wall St.
10 months ago
Jin Medical International Ltd. (NASDAQ:ZJYL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Yahoo Finance Video
10 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
Compare ZJYL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ZJYL JIN MEDICAL INTERNATIONAL LTD. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.